• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911416350
Device Problem Occlusion Within Device (1423)
Patient Problems Myocardial Infarction (1969); Reocclusion (1985)
Event Date 02/28/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2018-03130 (b)(6) study.It was reported that myocardial infarction (mi) and in-stent restenosis (isr) occurred.In (b)(6) 2012, the patient presented with mi without st elevation (nstemi) and unstable angina.The patient was referred for cardiac catheterization.Subsequently, coronary angiography and the index procedure were performed.The target lesion was a de novo lesion located in proximal right coronary artery (rca) extending to mid rca with 99% stenosis and was 30mm long with a reference vessel diameter of 4.0mm.The target lesion was treated with direct stent placement of a 3.00x24mm and 3.50x16.00mm promus element¿ plus stents with 0% residual stenosis.After three days, the patient was discharged on aspirin and prasugrel.In (b)(6) 2017, the patient presented to emergency room with complaints of central chest pain.The patient described the chest pain as a stabbing sensation associated with dyspnea on exertion and nausea.The patient also experienced fall at home.Subsequently, patient was hospitalized on the same day for further evaluation.In (b)(6) 2017, 80% discrete in-stent stenosis in mid rca was treated with predilatation and placement of 3.5 x 23 non-bsc drug-eluting stent.Following post dilatation the residual stenosis was 0%.Additionally, the patient received medication therapy in response to the event.On the following day, the event was considered as resolved and the patient was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7558012
MDR Text Key109699427
Report Number2134265-2018-05398
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 05/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/06/2013
Device Model NumberH7493911416350
Device Catalogue Number39114-1635
Device Lot Number0015172721
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/16/2018
Initial Date FDA Received05/31/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/06/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
-
-